| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.45 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |